Facebook
X
LinkedIn
ForwardHAI Prevention in Pediatrics 2018
Learning Objectives
- Evaluate recent data on screening for asymptomatic carriage of C. difficile and preferred first-line treatment of CDI and whether these data are applicable to children
- Discuss whether efforts should be focused on optimizing reliability to core CLABSI prevention bundle elements or adding new interventions beyond the current bundle
- Summarize practical approaches for performing VAE surveillance in children and data from the national 2017 pediatric VAE pilot
Course summary
Course opens:
07/02/2018
Course expires:
04/22/2019
Member cost:
$20.00
Cost:
$30.00